fda_recall · drug_recall · high

PAYLESS COMPOUNDERS, LLC — Class II recall: Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL via…

Event date
2026-04-22 00:00:00Z
Observed
2026-07-09 22:51:46Z
Source ID
D-0471-2026
Payload hash
9a1958539913239d8ee38751

Summary

Lack of Assurance of Sterility Status: Ongoing.

Informational only. Not legal, financial, or medical advice.